Prospectus Radiopharm Theranostics Limited ACN 647 877 889 For the offer of: a. up to 448,839,531 New Shares to Placement Subscribers at an issue price of $0.015 per New Share to raise up to $6.7 million through a two-tranche placement ( Placement Offer ); b. up to 400,000,000 New...
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-435
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Story so far
Earlier from Radiopharm Theranostics
- Notice Under Section 708A
- Application for quotation of securities - RAD
- Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
- RAD completes A$12.5 M placement and launches A$6 M SPP
- Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
Later from Radiopharm Theranostics
- Target market determination (TMD)
- Change in substantial holding
- Quarterly Activities/Appendix 4C Cash Flow Report
- Update - Proposed issue of securities - RAD
- Share Purchase Plan - Now Open
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics